Eyebright Medical Technology Plans GRD Listing on SIX Exchange to Raise RMB 1.4 Billion
Eyebright Medical Technology Co., Ltd (SHA: 688050), a Beijing-based company specializing in ophthalmic medical devices,...
Deals
CytoMed Therapeutics Partners with CNK Therapeutics for CAR Gene Grafting Technology
Singapore-based cell therapy developer CytoMed Therapeutics Ltd (NASDAQ: GDTC) has announced the signing of a...
Formosa Pharmaceuticals and Eyenovia Inc. Sign Licensing Deal for Ocular Surgery Treatment
Taiwan’s Formosa Pharmaceuticals (TPE: 6838) and US-based Eyenovia Inc., (NASDAQ: EYEN) have signed their second...
Medtronic’s Kanghui Partners with Huashan Hospital to Create Neuroscience Innovation Platform
US major Medtronic, Inc.’s (NYSE: MDT) unit, Kanghui, has entered into a partnership with Huashan...
Sanofi Misses Out on Acquiring Reata Pharmaceuticals to Biogen in USD 7.3 Billion Deal
Media outlet Bloomberg reported today that France-based Sanofi (NASDAQ: SNY) lost a bidding war to...
Gilead Sciences Enters Collaboration with Tentarix Biotherapeutics for Polyspecific Antibodies
Gilead Sciences (NASDAQ: GILD) has announced the initiation of three collaboration programs with US-based Tentarix...
Amoy Diagnostics and AstraZeneca Expand Collaboration on Companion Diagnostic Development
China-based Amoy Diagnostics Co., Ltd (AmoyDx, SHE: 300685) has announced a new cooperation agreement with...
HitGen Inc. Partners with Nested Therapeutics for Precision Medicine Research
China-based HitGen Inc. (SHA: 688222) has announced a research service agreement with Cambridge, Massachusetts-based precision...
Suzhou Leadsynbio Secures Series D Funding to Boost R&D and Market Presence
Suzhou Leadsynbio Technology Co., Ltd, a specialist in synthetic biology, has reported raised hundreds of...
Jiangsu Hengrui Pharmaceuticals Strikes Licensing Deal with One Bio Inc. for TSLP-Targeted mAb SHR1905
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276) has announced a significant licensing agreement with...
AstraZeneca to Invest Additional USD 250 Million in Qingdao for Aerosol Production Plant
UK pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) is set to invest an additional USD 250...
Eli Lilly Expands Portfolio with Acquisitions of Sigilon Therapeutics and Versanis Bio
Eli Lilly (NYSE: LLY) has completed the separate purchases of US compatriots Sigilon Therapeutics (NASDAQ:...
Novartis Acquires Chinook Therapeutics for $3.2 Billion, Eyes Kidney Disease Market
Switzerland-based pharmaceutical major Novartis (NYSE: NVS) has successfully completed the scheduled purchase of US-based kidney...
Novo Nordisk to Acquire Inversago Pharma in a Deal Valued Up to USD 1.1 Billion
Denmark’s leading pharmaceutical company, Novo Nordisk (NYSE: NVO), has reached an agreement to acquire Canada-based...
Eli Lilly Completes Acquisition of Dice Therapeutics for $2.0 Billion
Pharmaceutical giant Eli Lilly (NYSE: LLY) has successfully concluded the purchase of US-based Dice Therapeutics...
Cascade Pharmaceuticals Secures RMB140 Million in Financing to Advance FXR Agonist Clinical Trials
Shanghai-based sino-foreign joint venture, Cascade Pharmaceuticals, Inc., has reportedly raised RMB140 million in a recent...
Migrasome Therapeutics Secures Over RMB100 Million in Angel+ Funding Round
Beijing-based biotech startup Migrasome Therapeutics has reported raising upwards of RMB100 million in its angel...
Huadong Medicine Secures Exclusive Rights to Arcutis’ Daxas in Greater China and South-East Asia
Huadong Medicine Co., Ltd (SHE: 000963) has announced a significant licensing agreement with Arcutis (NASDAQ:...
Medtronic Partners with APMG to Advance Orthopedic Treatment Services in China
US-based Medtronic Inc., (NYSE: MDT) has entered into a partnership with China’s private healthcare group...
Everest Medicines and Shanghai Pharmaceuticals Deepen Partnership for Drug Distribution in China
China-based Everest Medicines (HKG: 1952) has announced a strategic partnership with Shanghai Pharmaceuticals marking a...